Wixela does cause weight gain in some people as weight gain is a possible side effect of Wixela.
Other possible side effects of Wixela include vaginal discharge, vaginal itching, feeling weak or very tired and mouth sores and mouth irritation.
The amount of puffs of Wixela inhaler you should take is 1 puff twice daily and around 12 hours apart.
Wixela is cheaper than Advair as Advair costs around $334.00 and Wixela costs around $115.00
A cheaper alternative to Advair is generic Symbicort which is a great alternative to the name brand Advair.
Advair HFA is an aerosol inhaler that is used twice a day and Advair Diskus is a powder inhaler which is also used twice a day.
Advair is better than Trelegy as Advair works better than Trelegy and has a rating of 7.2 out of 10 while Trelegy has a rating of only 6.5 out of 10.
Trelegy is better than Spiriva as Trelegy works better than Spirava and Trelegy has a higher rating than Spiriva.
You can get Spiriva cheaper through use of health insurance or even through Medicare or through RX savings cards.
The generic name for Spiriva Respimat is Tiotropium which can be much cheaper than the brand version of the same medication.
Spiriva is good for both COPD and Asthma although it should not be used for the relief of acute symptoms or rescue therapy.
Medicare does pay for Spiriva as 66 percent of Medicare prescription drug plans cover Spiriva.
The cheaper alternative for Spiriva Respimat is Advair Diskus and Xolair.
The inhaler that can replace Spiriva is Symbicort as well as Ventolin HFA, ProAir HFA, Breztri Aerosphere, Albuterol / Ipratropium and Combivent.
Spiriva is better than Albuterol as Spiriva has a rating of 5.7 while Abuterol has a rating of 3.2.
Spiriva is better than Symbicort for COPD.
Spiriva reduces the chances of a flare up or worsening of COPD better than Symbicort.
There are 2 types of short-acting bronchodilator inhaler: beta-2 agonist inhalers – such as salbutamol and terbutaline.
The best inhaler for stage 3 COPD is Xopenex (Levalbuterol) as well as Advair, Albuterol and Combivent Respimat.
The drug that should be avoided in patients with COPD are long acting beta agonists medications such as ipratropium.
Also COPD patients should avoid drugs such as prednisone and steroids.
The two most prescribed drug medications for COPD are Fluticasone (Flovent) and Budesonide (Pulmicort).
Another most commonly prescribed drug for COPD is Predisolone which comes in a shot, liquid or even pill form.
The drug that is triple therapy for COPD is budesonide/glycopyrrolate/formoterol fumarate that has co suspension delivery technology versus dual therapies.
The strongest medication for COPD is roflumilast (Daliresp) which is a phosphodiesterase-4 inhibitor.
The medication roflumilast decreases the airway inflammation and relaxes your airways.
Common side effects of roflumilast are weight loss and diarrhea.
The 3 medication inhaler for COPD is BREZTRI which is a 3 n 1 medicine and inhaler for COPD which combines 3 medicines which are an inhaled corticosteroid (ICS) medicine (budesonide), an anticholinergic medicine (glycopyrrolate), and a long acting beta2-adrenergic agonist (LABA) medicine (formoterol fumarate) in one inhaler.
Another inhaler medication for COPD is Tudorza.
The side effects of Tudorza are eye pain or eye redness, seeing halos or bright colors around lights, vomiting, nausea, blurred vision, difficult or painful urination, little or even no urination, or no improvement or worsening of your symptoms.
The indication of Tudorza is for the long term treatment of COPD and bronchospasm associated with chronic obstructive pulmonary disease which also includes emphysema and chronic bronchitis.
Tudorza inhaler is an anticholinergic inhaler that treats COPD by relaxing the muscles in the airways which opens the airways and makes it easier to breathe.
The cost of Tudorza is $337.00 for a supply of one Inhaler.
Tudorza should be taken as often as 2 times a day which is in the morning and in the evening by taking Tudorza 12 hours apart.
Tudorza is a long term bronchodilator treatment for people with COPD which includes emphysema and chronic bronchitis.
Tudorza is not a rescue inhaler and should not be used for treating sudden breathing problems.
Tudorza is for the long term treatment of COPD but you may also have a rescue inhaler prescribed that you should use for sudden breathing problems instead.
The active ingredient in Tudorza is a drug called aclidinium bromide.
Tudorza is not the same as Spiriva although they both contain anticholinergics.
However Spiriva contains the active drug called tiotropium bromide and Tudorza contains the active drug called aclidinium bromide.
Another name for Tudorza is aclidinium bromide.
Tudorza is an inhalation powder that is an anticholinergic that is for the long term treatment of COPD and bronchospasm associated with COPD which also includes emphysema and chronic bronchitis.
The class of drug that Tudorza is, is anticholinergics and contains the active drug called aclidinium.
Tudorza is not a steroid inhaler and instead is a long-acting muscarinic antagonist (LAMA) which works by relaxing the muscles around the airways in the lungs to help you breathe easier.
Tudorza inhaler is used for treating COPD also known as Chronic Obstructive Pulmonary Disease in adults.
COPD is a lung condition that gets worse over time such as chronic bronchitis and emphysema.
Tudorza Pressair (aclidinium) is not a steroid.
Tudorza is a long-acting muscarinic antagonist (LAMA) and it works by relaxing the muscles around the airways in the lungs to help you breathe easier.
Someone should go to the hospital with COPD if they experience or have trouble breathing at rest or they have trouble breathing or have any chest pain or are feeling confused or more sleepy than normal and if any rescue inhaler medications are not working.
The most common cause of death in COPD is respiratory failure.
With COPD you can usually walk 1 mile to 2 miles a day although some people with more severe COPD may only be ale to walk 1/2 mile or so.
Walking is good for you and can help improve your lung function when you have COPD and other lung issues.
COPD is not a terminal illness like cancer is as most people with treatment can live long lives with COPD although in some cases people with more severe COPD may die sooner than others.
Still COPD can cause death especially if not treated so it can be a terminal illness.
The 3 treatments for COPD are COPD medications, Pulmonary Rehabilitation and Noninvasive Ventilation.
Endobronchial Valve therapy and supplemental oxygen are other treatments for COPD as well as inhaler medications that can be used to treat COPD and improve breathing.
The average COPD patient lives for 10 years to 20 years although some may live a bit longer or shorter depending on their age and current overall health.
The way COPD progresses to death is over time your body is less able to take in the required amount of oxygen which then leads to death as you need enough oxygen to survive.